Atlas FDA

Floseal NT

FDA premarket approval P990009/S053 · decided 2019-04-18

Approval details

PMA number
P990009
Supplement
S053
Supplement type
Real-Time Process
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
Floseal NT
Generic name
Absorbable collagen hemostatic agent with thrombin
Applicant
Baxter Healthcare Corp
Date received
2019-01-22
Decision date
2019-04-18
Days to decision
86 days
Decision code
APPR
Product code
PMX
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Round Lake, IL
Statement
Approval for the removal of the co-packaging configuration of the 5,000 I.U. Thrombin-JMI component from the 5 mL Floseal Hemostatic Matrix.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
PrisMax System Version 2 (K190910)Baxter Healthcare Corp2019-07-25
PrisMax Control Unit (K163530)Baxter Healthcare Corp2017-05-03
ULTRAFUSE (K130531)Baxter Healthcare Corp2014-04-08
NEUTRAL LUER ACTIVATED DEVICE (ONE-LINK NEEDLE-FREE IV CONNECTOR) AND EXTENSION SETS (K132734)Baxter Healthcare Corp2013-10-08
LARGE BORE STOPCOCK WITH ROTATING MALE LUER LOCK/LARGE BORE STOPCOCK WITH EXTENSION SET, GANG LARGE BORE STOPCOCK MANIFO (K130245)Baxter Healthcare Corp2013-03-01
INTERLINK SYSTEM BURETROL SOLUTION SETS, INTERLINK SYSTEM BURETROL SOLUTION SETS, CONTINUED, CLEARLINK SYSTEM BURETROL S (K123874)Baxter Healthcare Corp2013-01-10
INTERLINK SYSTEM LEVER LOCK CANNULA WITH CHECK VALVE, SECONDARY MEDICATION SETS, SOLUTION SETS, CONTINU-FLO SOLUTION SET (K123868)Baxter Healthcare Corp2013-01-08
FLOWEASE [SUBCUTANEOUS] INFUSION SET (K121092)Baxter Healthcare Corp2012-06-29